The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection

Journal of Virology

Volumn 71, Issue 12, 1997, Pages 9508-9514

  Lifson, Jeffrey D ^a   Nowak, Martin A ^b   Goldstein, Simoy ^c   Rossio, Jeffrey L ^a   Kinter, Audrey ^c   Vasquez, Gabriela ^a   Wiltrout, Theresa A ^a   Brown, Charles ^c   Schneider, Douglas ^a   Wahl, Linda ^b   Lloyd, Alun L ^b   Williams, Jon ^d   Elkins, William R ^c   Fauci, Anthony S ^c   Hirsch, Vanessa M ^c  

^a SAIC FREDERICK INC   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d Genaera Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE COURSE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; INOCULATION; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIREMIA; VIRUS DIAGNOSIS; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0030775331     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.12.9508-9514.1997     Document Type: Article

References (68)

1. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR5: a RANTES. MIP-1α, MIP-1β, receptor as a fusion cofactor for macrophage tropic HIV-1. Science 272: 1955-1958.
2. Baskin, G. B., L. N. Martin, M. Murphey-Corb, F. S. Hu, D. Kuebler, and B. Davison. 1995. Distribution of SIV in lymph nodes of serially sacrificed rhesus monkeys. AIDS Res. Hum. Retroviruses 11:273-285.
3. Benveniste, O., B. Vaslin, R. Le Grand, P. Fouchet, V. Omessa, F. Theodore, P. Fretier, P. Clayette, F. Boussin, and D. Dormont. 1996. Comparative interleukin (IL)-2/interferon (IFN)-γ and IL-4/IL-10 responses during acute infection of macaques inoculated with attenuated nef-truncated or pathogenic SIVmac251 virus. Proc. Natl. Acad. Sci. USA 93:3658-3663.
4. Berson, J. F., D. Long, B. J. Doranz, J. Rucker, F. R. Jirik, and R. W. Doms. 1996. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains. J. Virol. 70: 6288-6295.
5. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
6. Busch, M. P., et al. 1997. 4th Conference on Retroviruses and Opportunistic Infection, 22 to 26 January 1997, Washington, D.C., abstr. 749.
7. Chakrabarti, L., M.-C. Cumont, L. Montagnier, and B. Hurtrel. 1994. Variable course of primary simian immunodeficiency virus infection in lymph nodes: relation to disease progression. J. Virol. 68:6634-6642.
8. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard, and J. Sodroski. 1995. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148.
9. Clark, S. J., M. S. Saag, W. E. Decker, S. Campbell-Hill, J. L. Roberson, P. H. Veldkamp, J. C. Kappes, B. H. Hahn, and G. M. Shaw. 1991. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N. Engl. J. Med. 324:954-960.
10. H2 hypothesis of HIV infection: new insights. Immunol. Today 15:575-581.
11. + T cells. Science 270:1811-1815.
12. Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation pathogenesis and therapy. Science 267:483-489.
13. Daar, E. S., T. Moudgil, R. D. Meyer, and D. D. Ho. 1991. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N. Engl. J. Med. 324:961-964.
14. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-667.
15. Doranz, B. J., J. Rucker, Y. Yi, R. J. Smyuth, M. Samson, S. C. Peiper, M. Parmentier, R. G. Collman, and R. W. Doms. 1996. A dual tropic primary HIV-1 isolate that uses fusion and the β-chemokine receptors CKR-5, CKR-3 and CKR-2B as fusion co-factors. Cell 85:1149-1158.
16. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673.
17. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-877.
18. H2 immunity in neonatal mice. Science 271:1728-1730.
19. Goldstein, S., W. R. Elkins, W. T. London, A. Hahn, R. Goeken, J. E. Martin, and V. M. Hirsch. 1994. Immunization with whole inactivated vaccine protects from infection by SIV grown in human but not macaque cells. J. Med. Primatol. 23:75-82.
20. Graziosi, C., et al. 1997. 4th Conference on Retroviruses and Opportunistic Infection, 22 to 26 January 1997, Washington. D.C., abstr. LB17.
21. Haase, A. T., K. Henry, M. Zupancic, G. Sedgewick, R. A. Faust, H. Melroe, W. Cavert, K. Gebhard, K. Staskus, Z. Q. Zhang, P. J. Dailey, H. H. Balfour, Jr., A. Erice, and A. S. Perelson. 1996. Quantitative image analysis of HIV-1 infection in lymphoid tissues. Science 274:985-989.
22. Haigwood, N. Personal communication.
23. Haigwood, N. L., A. Watson, W. F. Sutton, J. McClure, A. Lewis, J. Ranchalis, B. Travis, G. Voss, N. L. Letvin, S. L. Hu, V. M. Hirsch, and P. R. Johnson. 1996. Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile. Immunol. Lett. 510:107-114.
24. Hirsch, V., D. Adger-Johnson, B. Campbell, S. Goldstein, C. Brown, W. R. Elkins, and D. C. Montefiori. 1997. A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3. J. Virol. 71:1608-1615.
25. Hirsch, V. M., T. R. Fuerst, G. Sutter, M. W. Carroll, L. C. Yang, S. Goldstein, M. Piatak, Jr., W. R. Elkins, W. G. Alvord, D. C. Montefiori, B. Moss, and J. D. Lifson. 1996. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J. Virol. 70:3741-3752.
26. Hirsch, V. M., G. Dapolito, P. R. Johnson, W. R. Elkins, W. T. London, R. J. Montali, S. Goldstein, and C. Brown. 1995. Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with extent of in vivo replication. J. Virol. 69:955-967.
27. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
28. Koup, R. 1997. 4th Conference on Retroviruses and Opportunistic Infection, 22 to 26 January 1997, Washington, D.C., abstr. S37.
29. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary HIV-1 syndrome. J. Virol. 68:4650-4655.
30. Letvin, N. L., K. A. Reimann, Y. Yasutomi, D. H. Ringler, and H. Yamamoto. 1994. The SIVmac specific cytotoxic T lymphocyte response in the acutely infected rhesus monkey. Curr. Top. Microbiol. Immunol. 188:175-184.
31. + cells, Immunol. Today 17:217-224.
32. + cell anti-HIV responses in primary infection. Lancet 344:1671-1673.
33. Mellors, J. W., C. R. Rinaldo, Jr., P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170.
34. Mellors, J. W., L. A. Kingsley, C. R. Rinaldo, Jr., J. A. Todd, B. S. Hoo, R. P. Kokka, and P. Gupta. 1995. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 8:573-579.
35. Michael, N. L., A. E. Brown, R. F. Voigt, S. S. Frankel, J. R. Mascola, K. S. Brothers, M. Louder, D. L. Birx, and S. A. Cassol. 1997. Rapid disease progression without seroconversion following primary human immunodeficiency virus type 1 infection - evidence for highly susceptible human hosts. J. Infect. Dis. 174:1352-1359.
36. Moore, J. P., Y. Cao, D. D. Ho, and R. A. Koup. 1994. Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1. J. Virol. 68:5142-5155.
37. Moskophidis, D., M. Battegay, M. van den Broek, E. Laine, U. Hoffmann-Rohrer, and R. M. Zinkernagel. 1995. Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus. J. Gen. Virol. 76:381-391.
38. Moskophidis, D., F. Lechner, H. Hengartner, and R. M. Zinkernagel. 1994. MHC class I and non-MHC-linked capacity for generating an anti-viral CTL response determines susceptibility to CTL exhaustion and establishment of virus persistence in mice. J. Immunol. 152:4976-4983.
39. Nowak, M. A., A. L. Lloyd, G. M. Vasquez, T. A. Wiltrout, L. M. Wahl, N. Bischofberger, J. Williams, A. Kinter, A. S. Fauci, V. M. Hirsch, and J. D. Lifson. 1997. Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. J. Virol. 71:7518-7525.
40. Nowak, M. A., and C. R. M. Bangham. 1996. Population dynamics of immune responses to persistent viruses. Science 272:74-79.
41. O'Brien, T., W. A. Blattner, D. Waters, E. Eyster, M. W. Hilgartner, A. R. Cohen, N. Luban, A. Hatzakis, L. M. Aledort, P. S. Rosenberg, W. J. Miley, B. L. Kroner, J. J. Goedert, et al. 1996. Serum HIV-1 RNA levels and time to development of AIDS in the multicenter hemophilia cohort study. JAMA 276:105-110.
42. Operskalski, E. A., M. P. Busch, J. W. Mosley, D. O. Stram, and the Transfusion Safety Study Group. 1997. Comparative rates of disease progression among persons infected with the same or different HIV-1 strains. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 15:145-150.
43. Pantaleo, G., et al. 1997. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc. Natl. Acad. Sci. USA 94:254-259.
44. + T cells with a predominant V-beta usage during the primary immune response to HIV. Nature 370:463-467.
45. Pantaleo, G., C. Graziosi, J. F. Demarest, L. Butini, P. A. Pizzo, S. M. Schnittman, D. P. Kotler, and A. S. Fauci. 1991. Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 88:9838-9842.
46. Pantaleo, G., C. Graziosi, J. F. Demarest, L. Butini, M. Montrini, C. H. Fox, J. M. Orenstein, D. P. Kotler, and A. S. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355-358.
47. Paxton, W. A., S. R. Martin, D. Tse, T. R. O'Brien, J. Skurnick, N. L. VanDevanter, N. Padian, J. F. Braun, D. P. Kotler, S. M. Wolinsky, and R. A. Koup. 1996. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high risk sexual exposures. Nat. Med. 2:412-417.
48. Pellegrin, I., E. Legrand, D. Neau, P. Bonot, B. Masquelier, J. L. Pellegrin, J. M. Ragnaud, N. Bernard, and H. J. Fleury. 1996. Kinetics of appearance of neutralizing antibodies in 12 patients with primary or recent HIV-1 infection and relationship with plasma and cellular viral loads. J. Acquired. Immune Defic. Syndr. Hum. Retrovirol. 11:438-447.
49. Phillips, A. N. 1996. Reduction of HIV concentration during acute infection: independence from a specific immune response. Science 271:497-499.
50. Piatak, M., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K.-C. Luk, B. H. Hahn, G. M. Shaw, and J. D. Lifson. 1993. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749-1754.
51. Piatak, M., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K.-C. Luk, B. H. Hahn, G. M. Shaw, and J. D. Lifson. 1993. Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction (QC-PCR). AIDS 7:S65-S71.
52. Reimann, K. A., K. Tenner-Racz, P. Racz, D. C. Montefiori, Y. K. Yasutomi, B. J. Ransil, and N. L. Letvin. 1994. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Virol. 68:2362-2370.
53. Ridge, J. P., E. J. Fuchs, and P. Matzinger. 1996. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271:1723-1726.
54. Rossio, J. Unpublished data.
55. Ruprecht, R. M., and R. Bronson. 1994. Chemoprevention of retroviral infection: success is determined by virus inoculum strength and cellular immunity. DNA Cell Biol. 1:59-66.
56. Ruprecht, R. M., T. W. Baba, V. Liska, R. Bronson, D. Penninck, and M. F. Greene. 1996. Attenuated simian immunodeficiency virus in macaque neonates. AIDS Res. Hum. Retroviruses 12:459-460.
57. Safrit, J. T., and R. A. Koup. 1995. The immunology of primary HIV infection: which immune responses control HIV replication? Curr. Opin. Immunol. 7:456-461.
58. Sarzotti, M., D. S. Robbins, and P. M. Hoffman. 1996. Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 271: 1726-1728.
59. Schaker, T., A. C. Collier, J. Hughes, T. Shea, and L. Corey. 1996. Clinical and epidemiologic features of primary HIV infection. Ann. Intern. Med. 125:257-264.
60. Tsai, C. C., K. E. Follis, A. Sabo, T. W. Beck, R. F. Grant, N. Bischofberger, R. E. Benveniste, and R. Black. 1995. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science 270:1197-1199.
61. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563-1566.
62. Watson, A., J. Ranchalis, B. Travis, J. McClure, W. Sutton, P. R. Johnson, S. L. Hu, and N. L. Haigwood. 1997. Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival. J. Virol. 71:284-290.
63. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122.
64. Williams, L. M., and M. W. Cloyd. 1991. Polymorphic human gene(s) determines differential susceptibility of CD4 lymphocytes to infection by certain HIV-1 isolates. Virology 184:723-728.
65. + lymphocyte response in acutely infected rhesus monkeys. J. Virol. 67:1707-1711.
66. Zinkernagel, R. M. 1996. Immunology taught by viruses. Science 271:173-178.
67. Zinkernagel, R. M., and H. Hengartner. 1994. T cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS. Immunol. Today 15:262-268.
68. Zou, W., A. A. Lackner, M. Simon, I. Durand-Gasselin, P. Galanaud, R. C. Desrosiers, and D. Emilie. 1997. Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy. J. Virol. 71:1227-1236.